Dev

Dysregulation of TDP-43 expression in amyotrophic lateral sclerosis and frontotemporal lobar degeneration Investments < €500k Slovenia 2016    

Resolving the Mechanism of Neuroinflammation for the Innovative Therapy of Neurodegenerative Diseases Investments < €500k Slovenia 2016    

Pathogenic mechanism of the C9orf72 expanded hexanucleotide repeat mutation in neurodegeneration Investments < €500k Slovenia 2016    

Before Alzheimer’s Disease: novel mechanism of amyloid precursor protein signaling in adult healthy brain Investments < €500k Romania 2016    

Metal- and pH-induced conformational changes of peptides associated with neurodegenerative pathologies (METADIS) Investments < €500k Romania 2016    

Effects of 6-hydroxy-nicotine on chlorisondamine-induced oxidative stress and neurotoxicity: relevance for Alzheimer’s disease Investments < €500k Romania 2016    

Voltage gated sodium channel modulation of microglia activity in Alzheimer’s disease (NCmicroAD) Investments < €500k Romania 2016    

Neurodegeneration and Brain Diseases: A new instrumental approach of analysis and development of pharmaceutical formulations Investments < €500k Romania 2016    

Whole-exome sequencing of discordant and concordant affected sib pairs in spinocerebellar ataxia type 3 (SCA3): a tool to identify novel modifier genes and highlight disrupted molecular pathways. Investments < €500k Portugal 2016    

Targeting huntingtin proteostasis and mitochondria to prevent neuronal dysfunction in Huntington’s disease Investments < €500k Portugal 2016